What is Gyre Therapeutics, Inc.'s EV / sales?

Gyre Therapeutics, Inc. (GYRE) reported EV / sales of 5.1× in Q1 2026.

How has Gyre Therapeutics, Inc.'s EV / sales changed year-over-year?

Gyre Therapeutics, Inc.'s EV / sales decreased by 27.3% year-over-year, from 7× to 5.1×.

What is the long-term trend for Gyre Therapeutics, Inc.'s EV / sales?

Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s EV / sales has grown at a -43.1% compound annual growth rate (CAGR), from 17.1× to 5.5×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Gyre Therapeutics, Inc. GYRE EV / sales

EV / sales at other companies

Eli LillyLLY

11.9×-4.0×

Madrigal Pharmaceuticals, Inc.MDGL

10.7×-12.1×

Theravance BiopharmaTBPH

5.4×-0.5×

Rigel PharmaceuticalsRIGL

1.8×+0.4×

Zevra Therapeutics, Inc.ZVRA

3.7×-6.9×

LQD

Liquidia CorporationLQDA

10.8×-66.6×

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Calculated from Gyre Therapeutics, Inc.’s reported figures.

enterprise value/total revenue=5.1×

Based on the most recent quarter.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s EV / sales?: Gyre Therapeutics, Inc. (GYRE) reported EV / sales of 5.1× in Q1 2026.
How has Gyre Therapeutics, Inc.'s EV / sales changed year-over-year?: Gyre Therapeutics, Inc.'s EV / sales decreased by 27.3% year-over-year, from 7× to 5.1×.
What is the long-term trend for Gyre Therapeutics, Inc.'s EV / sales?: Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s EV / sales has grown at a -43.1% compound annual growth rate (CAGR), from 17.1× to 5.5×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.